Innoviva (INVA) Net Cash Flow (2010 - 2026)

Innoviva (INVA) posted Net Cash Flow of $52.1 million for Q1 2026, down 69.6% on a QoQ basis from $171.5 million in Q3 2025, and up 269.13% year-over-year from $14.1 million in Q1 2025.

Innoviva (INVA) Net Cash Flow (2010 - 2026) Analysis & Trends

Innoviva's Net Cash Flow history runs 17 years deep, the most recent figure standing at $52.1 million for Q1 2026.

  • Quarterly Net Cash Flow rose 269.13% year-over-year to $52.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $302.1 million (up 152.01% YoY) and the FY2025 annual result came in at $246.0 million, up 120.7% from the prior year.
  • Net Cash Flow was $52.1 million for Q1 2026 at Innoviva, down from $171.5 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $171.5 million in Q3 2025 and bottomed at -$147.0 million in Q1 2023.
  • A 5-year average of $27.6 million and a median of $38.6 million in 2024 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2023 — Net Cash Flow slumped 1062.23% — and 2026, when it jumped 269.13%.
  • Innoviva's Net Cash Flow stood at $99.3 million in 2022, then plunged by 211.83% to -$111.1 million in 2023, then jumped by 160.44% to $67.1 million in 2024, then surged by 155.6% to $171.5 million in 2025, then tumbled by 69.6% to $52.1 million in 2026.
  • Business Quant data shows INVA's Net Cash Flow at $52.1 million in Q1 2026, $171.5 million in Q3 2025, and $78.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 10.56 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.44 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 224.46 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 57.19 Mn
10 Innoviva 1.58 Bn 979.49 Mn 75.83 Mn 52.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 52.14 Mn
Mar 31, 2026 52.14 Mn
Sep 30, 2025 171.55 Mn
Sep 30, 2025 171.55 Mn
Jun 30, 2025 78.44 Mn
Jun 30, 2025 78.44 Mn
Mar 31, 2025 14.13 Mn
Mar 31, 2025 14.13 Mn
Sep 30, 2024 67.12 Mn
Sep 30, 2024 67.12 Mn
Jun 30, 2024 38.65 Mn
Jun 30, 2024 38.65 Mn
Mar 31, 2024 -15.16 Mn
Mar 31, 2024 -15.16 Mn
Sep 30, 2023 -111.05 Mn
Sep 30, 2023 -111.05 Mn
Jun 30, 2023 28.98 Mn
Jun 30, 2023 28.98 Mn
Mar 31, 2023 -147.00 Mn
Mar 31, 2023 -147.00 Mn